Serially measured blood biomarkers collected in the context of usual care, predict clinical outcome in a real-life heart failure population
Authors:
Open Access
- 10 March 2026
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 452, 134289
Abstract
No abstract availableKeywords
Funding Information
- Jaap Schouten Foundation
This publication has 31 references indexed in Scilit:
- Association of Long-term Change in N-Terminal Pro–B-Type Natriuretic Peptide With Incident Heart Failure and DeathJAMA Cardiology, 2023
- Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA‐HFEuropean Journal of Heart Failure, 2022
- Prognostic value of RDW alone and in combination with NT‐proBNP in patients with heart failureClinical Cardiology, 2022
- Toward personalized risk assessment in patients with chronic heart failure: Detailed temporal patterns of NT-proBNP, troponin T, and CRP in the Bio-SHiFT studyAmerican Heart Journal, 2018
- A Multimarker Multi-Time Point-Based Risk Stratification Strategy in Acute Heart Failure: Results from the RELAX-AHF TrialEuropean Journal of Heart Failure, 2017
- Gamma-Glutamyltransferase Rather Than Total Bilirubin Predicts Outcome in Chronic Heart FailureJournal of Cardiac Failure, 2011
- Association of Serial Measures of Cardiac Troponin T Using a Sensitive Assay With Incident Heart Failure and Cardiovascular Mortality in Older AdultsJAMA, 2010
- Prognostic Value of High-Sensitivity C-Reactive Protein in Heart Failure: A Systematic ReviewJournal of Cardiac Failure, 2009
- Worsening Renal Function and Prognosis in Heart Failure: Systematic Review and Meta-AnalysisJournal of Cardiac Failure, 2007
- C-reactive protein and risk of heart failure. The Rotterdam StudyAmerican Heart Journal, 2006